G713-0621 Screening compound: N-phenyl-5-(2-{[3-(1,2,3,4-tetrahydroisoquinolin-2-yl)propyl]carbamoyl}ethyl)-1,3,4-thiadiazole-2-carboxamide

G713-0621 Screening compound: N-phenyl-5-(2-{[3-(1,2,3,4-tetrahydroisoquinolin-2-yl)propyl]carbamoyl}ethyl)-1,3,4-thiadiazole-2-carboxamide
G713-0621 Screening compound: N-phenyl-5-(2-{[3-(1,2,3,4-tetrahydroisoquinolin-2-yl)propyl]carbamoyl}ethyl)-1,3,4-thiadiazole-2-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G713-0621
N-phenyl-5-(2-{[3-(1,2,3,4-tetrahydroisoquinolin-2-yl)propyl]carbamoyl}ethyl)-1,3,4-thiadiazole-2-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G713-0621

Molecular Formula

C24H27N5O2S (C24 H27 N5 O2 S)

Compound Name

N-phenyl-5-(2-{[3-(1,2,3,4-tetrahydroisoquinolin-2-yl)propyl]carbamoyl}ethyl)-1,3,4-thiadiazole-2-carboxamide

IUPAC name

N-phenyl-5-(2-{[3-(1234-tetrahydroisoquinolin-2-yl)propyl]carbamoyl}ethyl)-134-thiadiazole-2-carboxamide

SMILES

O=C(CCc1nnc(C(Nc2ccccc2)=O)s1)NCCCN(CC1)Cc2c1cccc2

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

449.58

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.519

Distribution Coefficient, logD

1.315

Water Solubility, LogSw

-2.84

Polar Surface Area

75.015

Acid Dissociation Constant (pKa)

11.40

Base Dissociation Constant (pKb)

8.58

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

33.30

G713-0621 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

GPCR Targeted Library (31838 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with G713-0621 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G713-0621?
Check Price and Availability of G713-0621, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G713-0621 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G713-0621
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G713-0621
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G713-0621 available by request